(Reuters) -Pfizer Inc and its accomplice BioNTech stated on Thursday the EU well being regulator has advisable authorising using their bivalent COVID-19 shot as a booster in kids aged 5 via 11.
The Omicron-tailored vaccine is already authorised by the European Fee for people aged 12 years and above.
The up to date bivalent booster shot targets the unique coronavirus pressure in addition to the BA.4 and BA.5 sub-variants of Omicron.
In October, European Medical Company backed authorization of Moderna Inc’s COVID-19 tailor-made booster photographs for 12 and above to additional vaccination campaigns within the area.
(Reporting by Bhanvi Satija and Khushi Mandowara in Bengaluru; Modifying by Shounak Dasgupta amd Shinjini Ganguli)
